This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
EpiCast Report: Dermatophytic Onychomycosis - Epidemiology Forecast to 2022
Summary Dermatophytic onychomycosis (DO) is an infection of the nail fold or nail plate with dermatophytes, a type of fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton flocossom (Sterry et al., 2006). DO begins as a white/yellow spot under the tip of the nail. As the infection spreads deeper, it causes further discoloration and thickening of the nail, resulting in nail disfigurement and pain/discomfort.
The high worldwide prevalence of DO is primarily due to changes in factors relating to lifestyle, customs, and culture. The incidence and prevalence of DO in the EU was stable over a period of 30 years between the 1960s and 1990s due to a decline in industries such as coal mining, representing decreased use of industrial baths, while simultaneously there has been an increase in prevalence resulting from the use of communal recreational facilities, which led to a constant incidence of DO (Roberts, 1992; Seebacher et al., 2008). In
Japan, the traditional Japanese practice of walking barefoot in the house, which facilitates the spread of the infection to family members, is the primary reason for the especially high prevalence and intensity of toenail fungal disease in
Japan (Nishimoto, 2006; Watanabe et al., 2010).
- The Dermatophytic Onychomycosis (DO) EpiCast Report provides an overview of the risk factors and global trends of DO in the seven major markets (US,
Spain, UK, and
Japan). - It also includes a 10-year epidemiology forecast of the prevalent cases of DO, segmented by sex, and age (15–29 years, 30–49 years, 50–69 years, and >70 years) in these markets.
Reasons to buy
- Develop business strategies by understanding the trends shaping and driving the global DO market.- Quantify patient populations in the global DO market to improve product design, pricing, and launch plans.- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for DO therapeutics in each of the markets covered.